Unicycive Therapeutics director Gaurav Aggarwal resigned from the board, with the company stating the departure was not due to any disagreement regarding operations, policies, or practices.
Key takeaways
Director Gaurav Aggarwal resigned from the Unicycive Therapeutics board effective April 6, 2026.
The resignation was not due to any disagreement with the company or its management on operational, policy, or practice matters.
The company expressed gratitude for Dr. Aggarwal's service on the board.
The event represents a change in board composition without disclosed operational conflict.